Invenomic Capital Management’s PVH PVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$42.7M Sell
575,346
-187,933
-25% -$16.1M 2.55% 6
2026
Q1
$53.2M Buy
763,279
+110,312
+17% +$7.24M 2.44% 4
2025
Q4
$43.8M Buy
652,967
+159,532
+32% +$12.5M 2.04% 9
2025
Q3
$41.3M Buy
493,435
+78,983
+19% +$6.2M 2% 10
2025
Q2
$28.4M Buy
414,452
+103,882
+33% +$7.54M 1.61% 17
2025
Q1
$20.1M Buy
+310,570
New +$25.1M 1.01% 26
2023
Q1
Sell
-63,122
Closed -$4.46M 173
2022
Q4
$4.46M Sell
63,122
-127,890
-67% -$7.62M 0.3% 92
2022
Q3
$8.56M Sell
191,012
-5,363
-3% -$318K 0.74% 49
2022
Q2
$11.2M Buy
+196,375
New +$13.6M 0.79% 42

Other funds holding PVH

Invenomic Capital Management's PVH Position: Q2 2026 in Review

Invenomic Capital Management reduced its PVH (PVH) stake by 25% in Q2 2026, selling an estimated $16.1M and leaving 575,346 shares worth $42.7M. The position accounts for 2.55% of the portfolio, ranked #6.

Invenomic Capital Management first reported a position in PVH in Q2 2022 and has held it in 9 quarters since. The position peaked at $53.2M in Q1 2026. 387 funds tracked by Wall St. Rank hold PVH as of Q2 2026.

  • Invenomic Capital Management held 575,346 shares of PVH worth $42.7M as of Q2 2026.
  • Invenomic Capital Management sold 187,933 PVH shares in Q2 2026, an estimated $16.1M.
  • PVH made up 2.55% of Invenomic Capital Management's portfolio in Q2 2026, its #6 holding.
  • Invenomic Capital Management first reported a position in PVH in Q2 2022 and has held it in 9 quarters since.
  • Invenomic Capital Management's PVH position peaked at $53.2M in Q1 2026.
  • 387 funds tracked by Wall St. Rank held PVH as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.